Home › Compare › RVLP vs BTI

RVLP vs BTI: Dividend Comparison 2026

RVLP yields 7092.20% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RVLP wins by $1884093739015635.50M in total portfolio value
10 years
RVLP
RVLP
● Live price
7092.20%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1884093739015635.50M
Annual income
$1,833,245,317,704,596,000,000.00
Full RVLP calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — RVLP vs BTI

📍 RVLP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRVLPBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RVLP + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RVLP pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RVLP
Annual income on $10K today (after 15% tax)
$602,836.88/yr
After 10yr DRIP, annual income (after tax)
$1,558,258,520,048,906,500,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, RVLP beats the other by $1,558,258,520,048,906,500,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RVLP + BTI for your $10,000?

RVLP: 50%BTI: 50%
100% BTI50/50100% RVLP
Portfolio after 10yr
$942046869507817.75M
Annual income
$916,622,658,852,298,000,000.00/yr
Blended yield
97.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

RVLP
Analyst Ratings
6
Buy
Consensus: Buy
Altman Z
-11.5
Piotroski
4/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RVLP buys
0
BTI buys
0
No recent congressional trades found for RVLP or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRVLPBTI
Forward yield7092.20% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$1884093739015635.50M ✓$37.7K
Annual income after 10y$1,833,245,317,704,596,000,000.00 ✓$2,786.64
Total dividends collected$1880686879940887.75M ✓$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: RVLP vs BTI ($10,000, DRIP)

YearRVLP PortfolioRVLP Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$719,920$709,219.86$11,299$598.92+$708.6K → RVLP
2$48,488,208$47,717,893.43$12,794$703.91+$48.48M → RVLP
3$3,055,533,336$3,003,650,953.86$14,518$829.07+$3055.52M → RVLP
4$180,164,837,337$176,895,416,667.11$16,513$978.64+$180164.82M → RVLP
5$9,940,782,885,418$9,748,006,509,468.02$18,827$1,157.84+$9940782.87M → RVLP
6$513,306,198,719,386$502,669,561,031,988.20$21,518$1,373.12+$513306198.70M → RVLP
7$24,807,223,019,401,092$24,257,985,386,771,350.00$24,657$1,632.46+$24807223019.38M → RVLP
8$1,122,195,624,531,859,500$1,095,651,895,901,100,200.00$28,329$1,945.74+$1122195624531.83M → RVLP
9$47,521,889,075,737,830,000$46,321,139,757,488,740,000.00$32,637$2,325.33+$47521889075737.80M → RVLP
10$1,884,093,739,015,635,500,000$1,833,245,317,704,596,000,000.00$37,708$2,786.64+$1884093739015635.50M → RVLP

RVLP vs BTI: Complete Analysis 2026

RVLP — Stock

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Full RVLP Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this RVLP vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RVLP vs SCHDRVLP vs JEPIRVLP vs ORVLP vs KORVLP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.